Cargando…

MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1

BACKGROUND: Epithelial ovarian cancer (EOC) is still a major gynecologic problem with poor 5 year survival rate due to distance metastases, despite routine surgery and chemotherapy. The precise underlying molecular mechanisms that trigger EOC migration and invasion are unclear. Recent studies sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hanwen, Wang, Qiuyu, Zhao, Qian, Di, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879084/
https://www.ncbi.nlm.nih.gov/pubmed/24279510
http://dx.doi.org/10.1186/1757-2215-6-84
_version_ 1782297916905357312
author Zhang, Hanwen
Wang, Qiuyu
Zhao, Qian
Di, Wen
author_facet Zhang, Hanwen
Wang, Qiuyu
Zhao, Qian
Di, Wen
author_sort Zhang, Hanwen
collection PubMed
description BACKGROUND: Epithelial ovarian cancer (EOC) is still a major gynecologic problem with poor 5 year survival rate due to distance metastases, despite routine surgery and chemotherapy. The precise underlying molecular mechanisms that trigger EOC migration and invasion are unclear. Recent studies suggest that the expression of microRNAs is widely dysregulated in ovarian cancer; and that they have evolved into tumorigenic processes, including cell proliferation, apoptosis and motility. METHODS: The expression of miR-124 was assessed in clinical ovarian cancer specimens and cell lines using miRNA qRTPCR. The function of miR-124 on cell migration and invasion was confirmed in vitro through wound healing assay and transwell assay. Luciferase reporter assay was used to confirm target associations. RESULTS: We showed that miR-124 is down-regulated in ovarian cancer specimens as well as in cell lines; and that low-level expression of miR-124 is much lower in highly metastatic ovarian cancer cells and tissues. Meantime, overexpression of miR-124 dramatically inhibits the motility of ovarian cancer cells in vitro and substantially suppresses the protein expression of SphK1, reported as an invasion and metastasis-related gene in human cancers, whose expression is markedly increased in both ovarian cancer cell lines and clinical samples, particularly in two highly metastasis cells, SKOV3-ip and HO8910pm as well as metastatic ovarian tumor tissues. Furthermore, SphK1 is identified as a direct target of miR-124, and knock-down of SphK1 in ovarian cancer cells, SKOV3-ip and HO8910pm, could mimic the inhibition of migration and invasion by miR-124, while re-introduction of SphK1 abrogates the suppression of motility and invasiveness induced by miR-124 in both cell lines. CONCLUSIONS: Our studies suggest a protective role of miR-124 in inhibition of migration and invasion in the molecular etiology of ovarian cancer, and a potentially novel application of miR-124 in the regulation of migration and invasion in EOC.
format Online
Article
Text
id pubmed-3879084
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38790842014-01-03 MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1 Zhang, Hanwen Wang, Qiuyu Zhao, Qian Di, Wen J Ovarian Res Research BACKGROUND: Epithelial ovarian cancer (EOC) is still a major gynecologic problem with poor 5 year survival rate due to distance metastases, despite routine surgery and chemotherapy. The precise underlying molecular mechanisms that trigger EOC migration and invasion are unclear. Recent studies suggest that the expression of microRNAs is widely dysregulated in ovarian cancer; and that they have evolved into tumorigenic processes, including cell proliferation, apoptosis and motility. METHODS: The expression of miR-124 was assessed in clinical ovarian cancer specimens and cell lines using miRNA qRTPCR. The function of miR-124 on cell migration and invasion was confirmed in vitro through wound healing assay and transwell assay. Luciferase reporter assay was used to confirm target associations. RESULTS: We showed that miR-124 is down-regulated in ovarian cancer specimens as well as in cell lines; and that low-level expression of miR-124 is much lower in highly metastatic ovarian cancer cells and tissues. Meantime, overexpression of miR-124 dramatically inhibits the motility of ovarian cancer cells in vitro and substantially suppresses the protein expression of SphK1, reported as an invasion and metastasis-related gene in human cancers, whose expression is markedly increased in both ovarian cancer cell lines and clinical samples, particularly in two highly metastasis cells, SKOV3-ip and HO8910pm as well as metastatic ovarian tumor tissues. Furthermore, SphK1 is identified as a direct target of miR-124, and knock-down of SphK1 in ovarian cancer cells, SKOV3-ip and HO8910pm, could mimic the inhibition of migration and invasion by miR-124, while re-introduction of SphK1 abrogates the suppression of motility and invasiveness induced by miR-124 in both cell lines. CONCLUSIONS: Our studies suggest a protective role of miR-124 in inhibition of migration and invasion in the molecular etiology of ovarian cancer, and a potentially novel application of miR-124 in the regulation of migration and invasion in EOC. BioMed Central 2013-11-26 /pmc/articles/PMC3879084/ /pubmed/24279510 http://dx.doi.org/10.1186/1757-2215-6-84 Text en Copyright © 2013 Zhang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Hanwen
Wang, Qiuyu
Zhao, Qian
Di, Wen
MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title_full MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title_fullStr MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title_full_unstemmed MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title_short MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1
title_sort mir-124 inhibits the migration and invasion of ovarian cancer cells by targeting sphk1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879084/
https://www.ncbi.nlm.nih.gov/pubmed/24279510
http://dx.doi.org/10.1186/1757-2215-6-84
work_keys_str_mv AT zhanghanwen mir124inhibitsthemigrationandinvasionofovariancancercellsbytargetingsphk1
AT wangqiuyu mir124inhibitsthemigrationandinvasionofovariancancercellsbytargetingsphk1
AT zhaoqian mir124inhibitsthemigrationandinvasionofovariancancercellsbytargetingsphk1
AT diwen mir124inhibitsthemigrationandinvasionofovariancancercellsbytargetingsphk1